Risk factors of advanced metachronous neoplasms in surveillance after colon cancer resection
Kwangwoo Nam, Jeong Eun Shin
Korean J Intern Med. 2021;36(2):305-312. Published online 2020 Apr 21 DOI: https://doi.org/10.3904/kjim.2019.053
Citations to this article as recorded by 
DMMR status and synchronous lesions predicts metachronous lesions after curative resection for rectal cancer
Xijie Chen, Junguo Chen, Liang Xu, Dezheng Lin, Xiaoling Hong, Junsheng Peng, Xiaowen He, Jiancong Hu
Frontiers in Surgery.2025;[Epub] CrossRef
Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study
Yoon Young Choi, Myeongjee Lee, Eun Hwa Kim, Jae Eun Lee, Inkyung Jung, Jae-Ho Cheong
JMIR Public Health and Surveillance.2024; 10: e48380. CrossRef
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions
Beatrice Salmaso, Melania Scarpa, Valerio Pellegrini, Astghik Stepanyan, Roberta Salmaso, Andromachi Kotsafti, Federico Scognamiglio, Dario Gregori, Giorgio Rivella, Ottavia De Simoni, Giulia Becherucci, Silvia Negro, Chiara Vignotto, Gaya Spolverato, Ces
Scientific Reports.2024;[Epub] CrossRef
Tumor microenvironment–responsive nanoformulations for breast cancer
Pallavi Velapure, Divyanshi kansal, Chandrashekhar Bobade
Discover Nano.2024;[Epub] CrossRef
Beyond colonoscopy: Physical activity as a viable adjunct to prevent colorectal cancer
Wei‐Yuan Chang, Han‐Mo Chiu
Digestive Endoscopy.2023; 35(1): 33. CrossRef
Recent Advance in Tumor Microenvironment-Based Stimuli-Responsive Nanoscale Drug Delivery and Imaging Platform
Fengzhi Cui, Jianhua Liu, Siwen Pang, Bo Li
Frontiers in Pharmacology.2022;[Epub] CrossRef